Chimeric Retinoid X Receptors and Their Use in a Novel Ecdysone Receptor-Based Inducible Gene Expression System
AssigneeIntrexon Corporation
InventorsMarianna Zinovievna KAPITSKAYA, Subba Reddy Palli
Life of this patent
Estimating the term…
Loading patent…
AssigneeIntrexon Corporation
InventorsMarianna Zinovievna KAPITSKAYA, Subba Reddy Palli
Estimating the term…
This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel ecdysone receptor/chimeric retinoid X receptor-based inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large-scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms.
A gene expression modulation system comprising:
(canceled)
4-5. (canceled)
7-13. (canceled)
A gene expression modulation system comprising:
(canceled)
17-25. (canceled)
A gene expression cassette comprising a polynucleotide encoding a hybrid polypeptide comprising a DNA-binding domain and a chimeric retinoid X receptor ligand binding domain.
28-31. (canceled)
A gene expression cassette comprising a polynucleotide encoding a hybrid polypeptide comprising a transactivation domain and a chimeric retinoid X receptor ligand binding domain.
33-35. (canceled)
An isolated polynucleotide selected from the group consisting of:
37-44. (canceled)
An isolated polynucleotide encoding a chimeric retinoid X receptor ligand binding domain, wherein the polynucleotide comprises a nucleic acid sequence selected from the group consisting of
(canceled)
An isolated chimeric retinoid X receptor polypeptide comprising an amino acid sequence selected from the group consisting of
(canceled)
(canceled)
55-56. (canceled)
58-59. (canceled)
61-62. (canceled)
64-65. (canceled)
Dependencies are inferred from the claim text.